Advertisment

Coronavirus: India's cumulative COVID-19 vaccination coverage exceeds 37.73 cr

author-image
Rajan Nath
New Update
Coronavirus: India's cumulative COVID-19 vaccination coverage exceeds 37.73 cr
Advertisment
Coronavirus India Updates: In a significant milestone in its fight against the deadly
Advertisment
COVID-19, India’s cumulative recoveries have exceeded the 3 crore mark. A total of 3,00,14,713 people have already recovered from
Advertisment
COVID-19 in India while 39,649 patients recovered in the last 24 hours, the Health Ministry stated while giving coronavirus updates about India. Also Read | Petrol and Diesel prices in India: Do you know how much are you paying as tax?
Advertisment
Coronavirus Update: India Records 37,154 New COVID-19 Cases; 724 Fatalities This constitutes an overall recovery rate of 97.22 percent, which is showing a sustained increasing trend. Also Read | Himachal Pradesh: Rains wreak havoc; cloudburst in Dharamshala triggers flood-like situation When will India be free of coronavirus? ICMR expert says COVID may become a  flu-like endemic | India News | Zee News On the other hand, the cumulative vaccination coverage of India has exceeded 37.73 crores. A total of 37,73,52,501 vaccine doses have been administered through 48,51,209 sessions, as per the provisional report till 7 am on Monday. Coronavirus News Highlights: Working Actively With Moderna To See How Its  COVID-19 Vaccine Can Be Made Available In India, Says Govt A total of 12,35,287 vaccine doses were administered in the last 24 hours. The new phase of COVID-19 vaccination commenced on June 21, 2021. India reported 37,154 daily new cases in the last 24 hours. Less than 50,000 daily new cases have been reported for 15 continuous days. Meanwhile, India’s Active Caseload stands at 4,50,899 while active cases were now only 1.46 percent of the country's total Positive Cases. -PTC News-
covid-19 coronavirus-india coronavirus coronavirus-india-updates covid-19-vaccination
Advertisment

Stay updated with the latest news headlines.

Follow us:
Advertisment